Literature DB >> 22816091

New adamantane derivatives can overcome resistance of influenza A(H1N1)pdm2009 and A(H3N2) viruses to remantadine.

V A Shibnev1, T M Garaev, M P Finogenova, E S Shevchenko, E I Burtseva.   

Abstract

New adamantane derivatives with amino acid residues and other bifunctional compounds were synthesized and their antiviral activity towards influenza A(H1N1)pdm and A(H3N2) viruses was studied. Some of these adamantane derivatives completely suppressed replication of remantadine-resistant influenza A virus strains.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22816091     DOI： 10.1007/s10517-012-1684-x

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  3 in total

1.  Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.

Authors:  Antonios Kolocouris; Christina Tzitzoglaki; F Brent Johnson; Roland Zell; Anna K Wright; Timothy A Cross; Ian Tietjen; David Fedida; David D Busath
Journal:  J Med Chem       Date:  2014-05-15       Impact factor: 7.446

2.  Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors-In Vitro, In Silico and QSAR Studies.

Authors:  Radoslav Chayrov; Nikolaos A Parisis; Maria V Chatziathanasiadou; Eleni Vrontaki; Kalliopi Moschovou; Georgia Melagraki; Hristina Sbirkova-Dimitrova; Boris Shivachev; Michaela Schmidtke; Yavor Mitrev; Martin Sticha; Thomas Mavromoustakos; Andreas G Tzakos; Ivanka Stankova
Journal:  Molecules       Date:  2020-09-01       Impact factor: 4.411

3.  New type of RNA virus replication inhibitor based on decahydro-closo-decaborate anion containing amino acid ester pendant group.

Authors:  Varvara V Avdeeva; Timur M Garaev; Natalia V Breslav; Elena I Burtseva; Tatyana V Grebennikova; Andrei P Zhdanov; Konstantin Yu Zhizhin; Elena A Malinina; Nikolay T Kuznetsov
Journal:  J Biol Inorg Chem       Date:  2022-03-25       Impact factor: 3.862
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.